Didang decoction attenuates cancer‐associated thrombosis by inhibiting PAD4‐dependent NET formation in lung cancer

Documenti analoghi

• Pretransplant NT‐proBNP levels are associated with mortality among lung transplant recipients
  di: Shimon Izhakian, et al.
  Pubblicazione: (2024)
• The European Voice of the Patient living with pulmonary hypertension associated with interstitial lung disease: Diagnosis, symptoms, impacts, and treatments
  di: Lucilla Piccari, et al.
  Pubblicazione: (2024)
• Delta‐like ligand 4 inhibitor drug treatment induces pulmonary hypertension in cancer clinical trials
  di: Casandra E. Besse, et al.
  Pubblicazione: (2024)
• Novel evaluation of pulmonary hypertension associated with chronic lung disease using perfusion SPECT/CT: A pilot study
  di: Kenichiro Atsumi, et al.
  Pubblicazione: (2024)
• Long‐Term Outcome of Pulmonary Artery Hypertension‐Specific Therapy in Patients With Portopulmonary Hypertension: A Multi‐Institutional Database Case Series Study
  di: Ding‐Sen Huang, et al.
  Pubblicazione: (2026)